Discover the latest articles and news in related subjects. In order to elucidate the potential role of ECP or pentostatin (either individually or in combination) in reducing the incidence of GVHD, we ...

Discover the latest articles and news in related subjects. In this prospective study, we analyzed response and prognostic variables in 25 steroid-refractory cGVHD patients treated with ECP on a twice- ...

Extracorporeal photopheresis (ECP) is a cell therapy based on UV light that was originally developed for the treatment of skin cancer (T-cell lymphomas) and has also been used since the early 1990s to ...

Extracorporeal photopheresis (ECP) is used to treat chronic graft-versus-host disease (cGVHD)—a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its use as a ...

ASTCT recently published an article in their journal Nucleus discussing extracorporeal photopheresis compared with acute graft-versus-host disease after receipt of hematopoietic stem cell transplant ...

-- Collaboration with experts in photopheresis field expected to further enhance understanding of photopheresis' effect on immune modulation across a range of severe and critical conditions -- -- ...

Researchers from the Vienna Lung Transplant Program of MedUni Vienna and University Hospital Vienna have published the first prospective, randomized and controlled study on the use of extracorporeal ...